VECTORMUNE® FP MG AE
Registration Number: G3852(Act 36/1947)
For the active immunization of chickens against Mycoplasma gallisepticum, Fowl Pox and Avian Encephalomyelitis
Dose Vials / Box
- 10 x 1,000 dose vials
Product information
VECTORMUNE ® FP MG AE
COMPOSITION
VECTORMUNE® FP MG + AE is a genetically engineered, live Fowl Pox virus vaccine tor use in chickens. The Fowl Pox virus has been genetically modified to express key protective Mycoplasma gallisepticum antigens. In addition to the
Fowl Pox virus vector, this freeze-dried vaccine contains a conventional live Avian Encephalomyelitis (AE) virus for use in the prevention of Avian Encephalomyelitis.
INDICATIONS
VECTORMUNE® FP MG + AE is recommended for wing web application to healthy, susceptible chickens eight weeks of age or older, but at least four weeks prior to the onset of egg production.
VECTORMUNE® FP MG + AE is indicated as an aid in the prevention of Fowl Pox, Mycoplasma gallisepticum infection and Avian Encephalomyelitis. Chickens receiving this vaccine must not have been previously exposed to fi eld fowl
poxvirus or pox vaccine due to interference with immunity following vaccination.
ADMINISTRATION AND DOSAGE
Wing Web: Insert the applicator into the webbed portion of the wing avoiding feathers, muscle, bone and blood vessels (0.01 ml dose/bird). Vaccine should be used within one hour.
STORAGE
– Store vaccine between +2°C and +8°C or 35°F and 45°F
– Protect from light
PACKAGED
10 x 1,000 dose vials with diluent and wing web applicators.